| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.8 |
| mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.8 |
| mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.8 |
| mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.9 |
| mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.9 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |